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A B S T R A C T
The cost of 3D printing has reduced dramatically over the last few years and is now within reach of many
scientiﬁc laboratories. This work presents an example of how 3D printing can be applied to the
development of custom laboratory equipment that is speciﬁcally adapted for use with the novel brain
tissue clearing technique, CLARITY. A simple, freely available online software tool was used, along with
consumer-grade equipment, to produce a brain slicing chamber and a combined antibody staining and
imaging chamber. Using standard 3D printers we were able to produce research-grade parts in an
iterative manner at a fraction of the cost of commercial equipment. 3D printing provides a reproducible,
ﬂexible, simple and cost-effective method for researchers to produce the equipment needed to quickly
adopt new methods.
ã 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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As research questions in neuroscience, and biomedical science
in general, become more complex, so too do the techniques
involved. Methodological advances also appear more frequently,
leading to a greater rush for research groups to utilise these within
their ﬁeld. However, each novel method brings its own problems in
the equipment that is required. A good example of this is tissue
clearing (Höckendorf et al., 2014; Kim et al., 2013), the process by
which biological tissue is rendered transparent to allow for light
microscopic investigation of large volumes of brain tissue. A
number of tissue-clearing methods have been recently developed
(Chung et al., 2013; Hama et al., 2011; Ke et al., 2013; Kuwajima
et al., 2013; Susaki et al., 2014), but the common factor amongst
them is that the volumes of tissue involved are orders of magnitude
greater than traditional histology, requiring custom laboratory
equipment for both the handling and imaging of samples.Abbreviations: ABS, acrylonitrile butadiene styrene; PLA, polylactic acid; FDM,
fused deposition modelling; SDS, sodium dodecyl sulphate; PFA, paraformalde-
hyde; STL, stereolithography.
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0378-5173/ã 2015 The Authors. Published by Elsevier B.V. This is an open access articLaboratory equipment for these novel techniques can be
produced in a number of ways. Commercial manufacturers will
develop equipment once experimental techniques have become
commonplace, but this is often too late for those researchers
wishing to quickly adopt a method and are frequently prohibitively
expensive. In addition, these products are often “generic” in nature,
so they may fail to precisely provide the desired function, delaying
further innovation. Alternatively, custom equipment can be
constructed using conventional manufacturing techniques: addi-
tive (e.g. welding), net shape (e.g. injection moulding) and
subtractive (e.g. machining). However, these methods are expen-
sive and require specialist equipment and training, which is
beyond many research groups. External collaborators or contrac-
tors may provide this equipment and knowledge, but this can be at
the expense of speed, which is required for the rapid prototyping of
custom parts.
Layered, additive manufacturing (3D printing) overcomes these
problems, allowing for rapid, simple and inexpensive prototyping
of custom parts for research. The concept has existed for some time
(Hull, 1986), but until recently it has remained expensive and
complicated, as is often the case with manufacturing techniques.
One method of 3D printing is fused deposition modelling (FDM),
(Crump, 1989), which has seen a dramatic decrease in the cost of
individual printers and is now readily available to the consumer
market. FDM printers are available in either kit form or fully
assembled for between $300 and $5000 depending on thele under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
3D printing parameters.
Model Brain slicing matrix Staining/imaging chamber
Printer MakerBot Replicator Mini MakerBot Replicator 2X
Filament PLA ABS
Supports No Yes
Raft Yes Yes
Inﬁll (%) 10 15
Shells 2 2
Layer height (mm) 0.2 0.1
Extruder temperature (C) 230 230
Build plate temperature (C) N/A 120
Extruder speed while extruding (mm/s) 90 90
Extruder speed while travelling (mm/s) 150 150
Model weight (g) 24.55 12.19
Model cost ($, approx.) 0.69 0.34
Print time (hours, approx.) 3 2
Fig. 1. Initial brain slicing matrix design.
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plastic ﬁlament and depositing a layer of material onto a moveable
platform. The platform then moves vertically away from the
printing head to allow the next layer to be deposited onto the
existing layers, allowing a 3D object to be generated. In addition to
the low cost, while previously 3D printing required in-depth
computer aided design knowledge, most simple parts can now be
developed with simple and freely-available tools.
The aim of this study was to explore the use of freely-available
software, along with inexpensive consumer grade FDM printers, to
produce custom equipment required for a novel tissue clearing
method: passive CLARITY (Chung et al., 2013; Tomer et al., 2014).
2. Materials and methods
2.1. Materials
Polylactic acid (PLA) and acrylonitrile butadiene styrene (ABS)
ﬁlaments were purchased from 3D FilaPrint (UK); 40% acrylamide
and 2% bis-acrylamide solutions from Bio-Rad (UK); 16% parafor-
maldehyde (PFA) solution from Alfa Aesar (UK); VA-044 photo-
initiator from Wako Chemicals (Germany); agarose from Roche
(UK); sodium dodecyl sulfate (SDS), boric acid and sodium
hydroxide (NaOH) from Sigma–Aldrich (UK); phosphate buffered
saline (PBS) tablets and glycerol from Fisher Scientiﬁc (UK).
2.2. Design software
All models were designed using Tinkercad software (www.
tinkercad.com) and exported as STL (STereoLithography) ﬁles to
MakerBot Desktop printers for printing. Final versions of the STL
ﬁles are available as Supplementary materials.
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.ijpharm.2015.03.042.
2.3. 3D printing
All models were produced using either a MakerBot Replicator
Mini (using PLA) or a MakerBot Replicator 2X (using ABS)
purchased from MakerBot Industries, LLC. All printing parameters
are shown in Table 1. Vernier callipers were used to verify the
model dimensions after printing.
2.4. Clearing
Adult (C57BL/6) mice were perfused with PBS and brain tissue
was ﬁxed with 4% PFA for 24 h. Following this, whole brains wereprepared according to the passive CLARITY protocol (Tomer et al.,
2014). Each brain was incubated in 40 ml of hydrogel solution (4%
acrylamide, 0.05% bis-acrylamide, 0.25% VA-044 and 4% PFA in PBS)
at 4 C for 10 days. The hydrogel was degassed using a vacuum pump,
a desiccation chamber and nitrogen gas before polymerisation at
37 C for 2 h. The brain was removed from the excess hydrogel and
embedded in a 6% agarose solution for sectioning. After sectioning,
the tissue was cleared in a 4% SDS solution in sodium borate buffer
(pH 8.5 with NaOH). Tissue sections were cleared at 37 C with
shaking, and the clearing buffer was replaced weekly until the slice
could be placed over printed text without visible distortion of the
letters. Prior to imaging, samples were incubated in refractive index
(RI) matching solution (85% glycerol) for 24 h.
3. Results and discussion
3.1. Brain slicing matrix
To achieve optimal tissue clearance and antibody staining using
the passive CLARITY protocol (Tomer et al., 2014) mouse brain
tissue is sectioned before clearing. Sectioning also complements
the use of more readily-available microscopy methods (confocal
and multiphoton imaging, rather than single-plane illumination
microscopy). Traditional rodent-brain matrices for sectioning
tissue are commercially available, but these are expensive
($200 for a single acrylic matrix and $350–$600 for a stainless
steel matrix). Further, each matrix is designed for brains of a
deﬁned species and age, which signiﬁcantly limits the ﬂexibility of
Fig. 2. Optimisation of slit width within a single design. (A) Model incorporating six potential slit widths. (B) Slit widths between 200 mM and 700 mM. (C) PLA print of the
model. (D) Determining the optimal slit width: razor blade ﬁts within the optimal width (400 mM).
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perfectly with the matrix. CLARITY renders tissue very soft and
difﬁcult to handle, so agarose embedding prior to sectioning and
clearance is desirable. Tissue matrices designed to slice blocks of
embedded tissue are also available, but these are equally expensive
($400) and inﬂexible.
We therefore aimed to produce a simple design that could be
used to section brain tissue in a reliable and reproducible manner,
and which could be rapidly adapted to changing experimental
design. It was also important that the matrix could be designed
using freely available software and printed using a consumer grade
FDM printer.
Of the available 3D-design tools which can be used with FDM,
we chose Tinkercad. This is a free online tool that allows extremely
simple 3D design for non-specialists. Rather than adopting a
complex 3D approach, a number of pre-deﬁned shapes can be
easily combined into the ﬁnal design. Fig. 1 shows the initial design
for the brain slicing matrix. This shape would allow an agarose
embedded brain to be accurately sectioned into 2-mm-thick
coronal slices using a razor blade, which could then be easily
removed from the matrix without damaging the tissue.
One of the limitations of consumer grade FDM printers is their
spatial resolution. The nature of fused deposition means that there
can be ‘blurring’ of the print when the printing nozzle moves theplastic from its precise, intended location. This can lead to very ﬁne
details being obscured and small gaps being ﬁlled in. The “slits” in
the design in Fig. 1 need to be exactly 2 mm apart for precise
sectioning. However, the width of the slits themselves needs to be
sufﬁciently wide to allow a razor blade to ﬁt into them, but narrowFig. 3. Final PLA print of brain slicing matrix with 400 mM slits.
Fig. 4. Application of brain slicing matrix. (A–C) Using the brain slicing matrix to generate coronal sections of an adult mouse brain embedded in agarose. (D) 2 mm coronal
mouse brain slices, ready for clearing using CLARITY.
Fig. 5. 2 mm coronal mouse brain section following clearing with CLARITY. 
654 A.L. Tyson et al. / International Journal of Pharmaceutics 494 (2015) 651–656enough to keep the blade perpendicular to the tissue surface,
allowing for accurate and reproducible sectioning. To quickly
determine the slit width needed, another model (Fig. 2A) was
produced. This model was simply a modiﬁcation of the original
design in which the slit widths varied between 200 mM and
700 mM at 100 mM intervals (Fig. 2B). The relative ease and speed
of 3D printing, coupled with the use of inexpensive ﬁlaments,
meant that it was simple to rapidly optimise designs, including (as
here) in a single print.
The model in Fig. 2A was printed on both a MakerBot Replicator
Mini (using PLA) and a MakerBot Replicator 2X (using ABS), both
inexpensive consumer grade FDM printers. The optimal design was
printed on the MakerBot Replicator Mini using PLA. Final 3D
printing parameters are outlined in Table 1.Fig. 6. Combined staining/imaging chamber design.
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MakerBot Replicator Mini. Fig. 2D shows the model with a razor
blade in the 400 mM slit, which was the optimal thickness for the
ﬁnal print. The ﬁnal print is shown in Fig. 3. This model was then
successfully used to section an agarose-embedded mouse brain
into accurate 2 mm slices (Fig. 4) ready to be cleared.
3.2. Staining and imaging chamber
In CLARITY, following sectioning and clearing, the tissue can be
antibody stained and imaged. This presents two problems. First,
the cleared tissue (Fig. 5) is very fragile, and moving it between
containers can potentially damage it. Second, traditional sample-
mounting set-ups (a glass slide and coverslip) are not well
designed for the imaging of large volumes of tissue for extended
periods of time. To overcome these issues, a combined staining andFig. 7. Staining/imaging chamber. (A) ABS print of the combined staining/imaging chamb
of a cleared slice in the chamber.imaging chamber was designed. The goal was to ensure that the
cleared tissue sections could be transferred to this container,
allowing staining, washing, matching and imaging to then be
performed without handling the sample.
A chamber was designed (Fig. 6) for this purpose, including a
ﬁlling/aspiration port to prevent contact with the sample. The
chamber was sized to ﬁt tissue which had been sectioned using the
3D printed matrix shown in Fig. 3. In addition, the design
incorporated a small slit in the top for insertion of a standard
22  40 mm coverslip, allowing imaging within the chamber on a
conventional upright confocal or multiphoton microscope. The
model was printed vertically (on the smallest end) and with
removable supports to allow the overhangs to be produced. The
Replicator 2X was used with ABS, as ABS is more resistant to
degradation than PLA (necessary for long antibody incubations).
The ﬁnal print is shown in Fig. 7A. This chamber can then be useder. (B) Filling the chamber with antibody solution for staining. (C) Confocal imaging
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microscopy (Fig. 7C). The custom size of the chamber also helps to
reduce the amount of expensive antibody solution and RI matching
solution required to the minimum necessary.
4. Conclusion
The present study shows how custom laboratory equipment can
be designed, tested and built easily and simply using freely
available software, and consumer grade 3D printing equipment.
This application to a novel tissue clearing method (passive
CLARITY) is just one of many within biomedical science.
Applications to both magnetic resonance imaging (Herrmann
et al., 2014) and in vitro electrophysiology (Hyde et al., 2014) have
been published previously.
While 3D printing has been available for some time, it is only
very recently that the technology could be readily adopted by most
laboratories. The software used in this study is very simple, and can
be employed to design a wide variety of parts after only a few
minutes of training. The printing software is also very easy to use,
and works with commercially available printers. In addition,
consumer-grade printers require far less maintenance than self-
assembled machines. For example, exchangeable ﬁlament-extru-
sion heads such as those available with the MakerBot Replicator
Mini’s reduce printer downtime due to blocked extruders.
Researchers can therefore devote their time to the research
question at hand rather than making parts or maintaining
equipment.
One of the most important aspects of any scientiﬁc study is
reproducibility. 3D printing provides this both within a study, and
for replication. Once a part has been designed, any number of
copies can be made to allow for a consistent experimental set-up.
Once a study has been published, both the model design (STL ﬁle)
and the printing parameters can be made freely available, allowing
anyone to reproduce the work using exactly the same equipment.
Another key beneﬁt of 3D printing is the ﬂexibility it allows.
Commercial products are extremely inﬂexible, and traditional
manufacturing requires a great deal of time, effort and money to
adapt designs. The models used in this study are good examples. If
the optimal slice thickness for CLARITY was to be changed, it would
be trivial to adapt the brain matrix to slice at a different thickness,
and to change the staining/imaging chamber to accommodate a
different size slice. Similarly, should it become necessary to dissect
a particular brain area for analysis (as opposed to simple slices), a
brain atlas could be used to design a chamber to allow for accurate
and reproducible dissection of speciﬁc brain regions very easily.
Lastly, the main beneﬁt of 3D printing, particularly the
approach used in this study, is the cost. 3D printers require an
initial outlay, but this cost is reducing each year. The printers used
in this study retail at approximately $1500 (MakerBot Replicator
Mini) and $3000 (MakerBot Replicator 2X) in the UK. While this
cost is not trivial, it compares very well to laboratory equipment ingeneral. The running costs of the machines, however, are
extremely low. One kilogram of PLA or ABS ﬁlament can be
purchased for under $30, and so even with prototyping, each of the
parts printed in this study cost less than $1. Compared to $170–
$650 for a commercially produced matrix, 3D printers are
extremely cost-effective for producing equipment and are now a
viable option for most research groups.
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